Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines

被引:76
作者
Zanin-Zhorov, A
Bruck, R
Tal, G
Oren, S
Aeed, H
Hershkoviz, R
Cohen, IR [1 ]
Lider, O
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] E Wolfson Med Ctr, Dept Gastroenterol, Holon, Israel
[3] Dept Internal Med D, Zerifin, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.4049/jimmunol.174.6.3227
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Extracellular heat shock protein 60 (HSP60) has been considered a proinflammatory danger signal. Yet, HSP60 can also down regulate experimental immune arthritis and diabetes models by specific inhibition of Th1-like responses. We now report that HSP60 in vitro differentially modulates the expression of Th1/Th2 transcription factors in human T cells: HSP60 down-regulates T-bet, NF-kappaB, and NFATp and up-regulates GATA-3, leading to decreased secretion of TNF-alpha and IFN-gamma and enhanced secretion of IL-10. These effects depended on TLR2 signaling and could not be attributed to LPS or to other contaminants. In BALB/c mice, HSP60 in vivo inhibited the clinical, histological, and serological manifestations of Con A-induced hepatitis associated with up-regulated T cell expression of suppressor of cytokine signaling 3 and GATA-3 and down-regulated T-bet expression. These results provide a molecular explanation for the effects of HSP60 treatment on T cell inflammation via innate regulation of the inflammatory response.
引用
收藏
页码:3227 / 3236
页数:10
相关论文
共 44 条
  • [1] Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos
    Agrawal, S
    Agrawal, A
    Doughty, B
    Gerwitz, A
    Blenis, J
    Van Dyke, T
    Pulendran, B
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (10) : 4984 - 4989
  • [2] Toll-like receptor signaling pathways
    Barton, GM
    Medzhitov, R
    [J]. SCIENCE, 2003, 300 (5625) : 1524 - 1525
  • [3] Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces th2-type antibodies
    Bockova, J
    Elias, D
    Cohen, IR
    [J]. JOURNAL OF AUTOIMMUNITY, 1997, 10 (04) : 323 - 329
  • [4] Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
    Coccia, EM
    Severa, M
    Giacomini, E
    Monneron, D
    Remoli, ME
    Julkunen, I
    Cella, M
    Lande, R
    Uzé, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) : 796 - 805
  • [5] A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells
    Dillon, S
    Agrawal, A
    Van Dyke, T
    Landreth, G
    McCauley, L
    Koh, A
    Maliszewski, C
    Akira, S
    Pulendran, B
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (08) : 4733 - 4743
  • [6] Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens
    Elias, D
    Meilin, A
    Ablamunits, V
    Birk, OS
    Carmi, P
    KonenWaisman, S
    Cohen, IR
    [J]. DIABETES, 1997, 46 (05) : 758 - 764
  • [7] Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages
    Gao, BC
    Tsan, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) : 22523 - 22529
  • [8] NF-κB and rel proteins:: Evolutionarily conserved mediators of immune responses
    Ghosh, S
    May, MJ
    Kopp, EB
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 225 - 260
  • [9] Glimcher LH, 2000, GENE DEV, V14, P1693
  • [10] HOMUNG V, 2002, J IMMUNOL, V168, P4531